Healthcare & Life Sciences
Kesmalea
United Kingdomkesmalea.com
Kesmalea is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Kesmalea
Kesmalea is a company headquartered in the United Kingdom. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Kesmalea develops novel oral, CNS-penetrant small-molecule targeted protein degraders using its SELFTAC® platform for treating oncology and central nervous system diseases.
Explore Kesmalea's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.